Correlation Between Neuropace and LENSAR

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and LENSAR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and LENSAR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and LENSAR Inc, you can compare the effects of market volatilities on Neuropace and LENSAR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of LENSAR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and LENSAR.

Diversification Opportunities for Neuropace and LENSAR

-0.27
  Correlation Coefficient

Very good diversification

The 3 months correlation between Neuropace and LENSAR is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and LENSAR Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LENSAR Inc and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with LENSAR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LENSAR Inc has no effect on the direction of Neuropace i.e., Neuropace and LENSAR go up and down completely randomly.

Pair Corralation between Neuropace and LENSAR

Given the investment horizon of 90 days Neuropace is expected to generate 4.52 times less return on investment than LENSAR. But when comparing it to its historical volatility, Neuropace is 1.54 times less risky than LENSAR. It trades about 0.06 of its potential returns per unit of risk. LENSAR Inc is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  866.00  in LENSAR Inc on December 30, 2024 and sell it today you would earn a total of  547.00  from holding LENSAR Inc or generate 63.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Neuropace  vs.  LENSAR Inc

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
LENSAR Inc 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in LENSAR Inc are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain basic indicators, LENSAR reported solid returns over the last few months and may actually be approaching a breakup point.

Neuropace and LENSAR Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and LENSAR

The main advantage of trading using opposite Neuropace and LENSAR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, LENSAR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LENSAR will offset losses from the drop in LENSAR's long position.
The idea behind Neuropace and LENSAR Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites